Respiratory Medicine
Volume 100, Issue 11 , Pages 1997-2003 , November 2006

The impact of bronchiectasis associated to sinonasal disease on quality of life

  • J.M. Guilemany

      Affiliations

    • Rhinology Unit, Department of Otorhinolaryngology, Hospital Clinic de Barcelona, ENT, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34932279872; fax: +34932275454.
    • ,
  • I. Alobid

      Affiliations

    • Rhinology Unit, Department of Otorhinolaryngology, Hospital Clinic de Barcelona, ENT, Barcelona, Spain
    • Department of Otorhinolaryngology, Hospital Municipal de Badalona, Badalona, Spain
    • ,
  • J. Angrill

      Affiliations

    • Department of Pneumology, Hospital Clínic, Department of Medicine, University of Barcelona, Spain
    • ,
  • F. Ballesteros

      Affiliations

    • Rhinology Unit, Department of Otorhinolaryngology, Hospital Clinic de Barcelona, ENT, Barcelona, Spain
    • ,
  • M. Bernal-Sprekelsen

      Affiliations

    • Rhinology Unit, Department of Otorhinolaryngology, Hospital Clinic de Barcelona, ENT, Barcelona, Spain
    • ,
  • C. Picado

      Affiliations

    • Department of Pneumology, Hospital Clínic, Department of Medicine, University of Barcelona, Spain
    • ,
  • J. Mullol

      Affiliations

    • Rhinology Unit, Department of Otorhinolaryngology, Hospital Clinic de Barcelona, ENT, Barcelona, Spain
    • Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Received 20 September 2005 ,Accepted 19 February 2006.

References 

  1. Barker AL. Bronchiectasis. N Engl J Med. 2002;346:1383–1393
  2. Larsen PL, Tos M. Origin and structure of nasal polyps. In:  Mygind N,  Lildholdt T editor. Nasal polyposis: an inflammatory disease and its treatment. Copenhagen: Munksgaard; 1997;p. 17–30
  3. Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al. EAACI. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60(5):583–601
  4. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc. 1996;17:231–236
  5. Widal MF, Abrani P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med. 1922;30:189–192
  6. Jones PW, Quirk FH, Baveystock CM. Why quality of life measures should be used in the treatment of patients with respiratory illness. Monaldi Arch Chest Dis. 1994;49:79–82
  7. Chan SL, Chan-Yeung MM, Ooi GC, Lam CL, Cheung TF, Lam WK, et al. Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest. 2002;122:2030–2037
  8. Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, de la Fuente L. Population reference values of the Spanish version of the Health Questionnaire SF-36. Med Clin (Barc). 1998;111:410–416
  9. Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of life in COPD study group. J Clin Epidemiol. 1998;51:1087–1094
  10. Alonso J, Ferrer M, Gandek B, Ware JE, Aaronson NK, Mosconi P, et al. IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13:283–298
  11. Alobid I, Benítez P, Bernal-Sprekelsen M, Guilemany JM, Picado C, Mullol J. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res. 2005;14:789–793
  12. Alobid I, Benítez P, Bernal M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life. Comparison between the effects of medical and surgical treatments. Allergy. 2005;60:452–458
  13. Ware JE, Konsinski M, Keller SD. SF-36 Physical and mental health summary scales: a user's manual. Boston, MA: The Health Institute, New England Medical Center; 1994;
  14. Rasp G, Schuk A, Kastenbauer ER. A new grading system for nasal polyps of the ethmoid bone. HNO-on line, 1996. http://www.link.springer.de/link/service/journals/00106
  15. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol. 1995;20:26–30
  16. Johansen LV, Illum P, Kristensen S, Winther L, Petersen SV, Synnerstad B. The effect of Budesonide (Rhinocort®) in the treatment of small and medium sized nasal polyps. Clin Otolaryngol. 1993;18:524–527
  17. Cronbach LJ. Coefficient alpha and internal structure of a test. Psychometrika. 1951;16:297–334
  18. Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med. 1994;149:371–375
  19. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157:123–128
  20. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000;162:1391–1396
  21. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros. 2003;2:206–213
  22. Engstrom CP, Persson LO, Larsson S, Sullivan M. Reliability and validity of a Swedish version of the St. George's Respiratory Questionnaire. Eur Respir J. 1998;11:61–66
  23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. Georges's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327
  24. Knebel AR, Leidy NK, Sherman S. Health related quality of life and disease severity in patients with alpha-1 antitrypsin deficiency. Qual Life Res. 1999;8:385–391
  25. Chang JA, Curtis R, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116:1175–1182
  26. Wilson CB, Jones PW, O’Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156:536–541
  27. O’Leary CJ, Wilson CB, Hansell DM, Cole PJ, Wilson R, Jones PW. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002;96:686–692
  28. Hernandez C, Abreu J, Jimenez A, Fernandez R, Martin C. Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis. Med Clin (Barc). 2002;118:130–134
  29. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother. 2005;49:3382–3386
  30. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:891–897
  31. Gillespie MB, Osguthorpe JD. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Curr Allergy Asthma Rep. 2004;4:478–485
  32. Johansson L, Bramerson A, Holmberg K, Melen I, Akerlund A, Bende M. Clinical relevance of nasal polyps in individuals recruited from a general population-based study. Acta Otolaryngol. 2004;124:77–81
  33. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol. 1999;104:79–84
  34. Alobid I, Benítez P, Pujols L, Maldonado M, Bernal-Sprekelsen M, Morelló A, et al. Severe nasal polyposis and its impact on quality of life. The effect of short course of oral steroids followed by long term intranasal steroids treatment. Rhinology. 2006;44:8–13
  35. Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg. 1997;117:12–17
  36. Winstead W, Barnett S. Impact of endoscopic sinus surgery on global health perception: an outcomes study. Otolaryngol Head Neck Surg. 1998;119:486–491
  37. Durr DG, Desrosiers MY, Dassa C. Quality of life in patients with rhinosinusitis. J Otolaryngol. 1999;28:108–111
  38. Wang PC, Tai CJ, Lin MS, Chu CC, Liang SC. Quality of life in Taiwanese adults with chronic rhino-sinusitis. Qual Life Res. 2003;12:443–448
  39. Failde I, Ramos I. Validity and reliability of the SF-36 health survey questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000;53:359–365
  40. Espinosa De Los Monteros MJ, Alonso J, Ancochea J, Gonzalez A. Quality of life in asthma: reliability and validity of the short form generic questionnaire (SF-36) applied to the population of asthmatics in a public health area. Arch Bronconeumol. 2002;38:4–9

PII: S0954-6111(06)00101-6

doi: 10.1016/j.rmed.2006.02.016

Respiratory Medicine
Volume 100, Issue 11 , Pages 1997-2003 , November 2006

Article Tools

* Image Usage & Resolution